Effect of Repeated Intravitreal Injections in Glaucoma Spectrum Diseases

References

• Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2019;3:CD005139.
   PubMed Web of Science ®Google Scholar
• Ehlers JP, Yeh S, Maguire MG, et al. Intravitreal pharmacotherapies for diabetic macular edema: a report by the American Academy of Ophthalmology. Ophthalmology. 2022;129(1):88–99.
   PubMed Web of Science ®Google Scholar
• Shalchi Z, Mahroo O, Bunce C, Mitry D. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Database Syst Rev. 2020;7:CD009510.
   PubMedGoogle Scholar
• Hoguet A, Chen PP, Junk AK, et al. The effect of anti-vascular endothelial growth factor agents on intraocular pressure and glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2019;126(4):611–622. doi:10.1016/j.ophtha.2018.11.019
   PubMed Web of Science ®Google Scholar
• Chopra R, Preston GC, Keenan TDL, et al. Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye. 2022;36(7):1373–8.
   PubMed Web of Science ®Google Scholar
• Ghanchi F, Bourne R, Downes SM, et al. An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma. Eye. 2022;36(6):1154–1167. doi:10.1038/s41433-021-01766-w
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou M, Xia S, Jing Q, Gao L. Sustained elevation of intraocular pressure associated with intravitreal administration of anti-vascular endothelial growth factor: a systematic review and meta-analysis. Sci Rep. 2016;6(1):39301. doi:10.1038/srep39301
   PubMed Web of Science ®Google Scholar
• Atchison EA, Wood KM, Mattox CG, Barry CN, Lum F, MacCumber MW. The real-world effect of intravitreous anti-vascular endothelial growth factor drugs on intraocular pressure: an analysis using the iris registry. Ophthalmology. 2018;125(5):676–682. doi:10.1016/j.ophtha.2017.11.027
   PubMed Web of Science ®Google Scholar
• de Vries VA, Bassil FL, Ramdas WD. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis. Sci Rep. 2020;10(1):13248. doi:10.1038/s41598-020-70269-7
   PubMed Web of Science ®Google Scholar
• Levin AM, Chaya CJ, Kahook MY, Wirostko BM. Intraocular pressure elevation following intravitreal anti-VEGF injections: short- and long-term considerations. J Glaucoma. 2021;30(12):1019–1026. doi:10.1097/IJG.0000000000001894
   PubMed Web of Science ®Google Scholar
• Nuesi R, Swaminathan SS. Effect of intravitreal injections on retinal imaging metrics in glaucomatous and non-glaucomatous eyes. Curr Ophthalmol Rep. 2020;8(3):111–119. doi:10.1007/s40135-020-00235-z
   PubMedGoogle Scholar
• Horsley MB, Mandava N, Maycotte MA, Kahook MY. Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy. Am J Ophthalmol. 2010;150(4):558–61 e1. doi:10.1016/j.ajo.2010.04.029
   PubMed Web of Science ®Google Scholar
• Martinez-de-la-Casa JM, Ruiz-Calvo A, Saenz-Frances F, et al. Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab. Invest Ophthalmol Vis Sci. 2012;53(10):6214–6218. doi:10.1167/iovs.12-9875
   PubMed Web of Science ®Google Scholar
• Sobaci G, Gungor R, Ozge G. Effects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure: a comparative clinical study. Int J Ophthalmol. 2013;6(2):211–215. doi:10.3980/j.issn.2222-3959.2013.02.20
   PubMed Web of Science ®Google Scholar
• Shin HJ, Shin KC, Chung H, Kim HC. Change of retinal nerve fiber layer thickness in various retinal diseases treated with multiple intravitreal antivascular endothelial growth factor. Invest Ophthalmol Vis Sci. 2014;55(4):2403–2411. doi:10.1167/iovs.13-13769
   PubMed Web of Science ®Google Scholar
• Demirel S, Batioğlu F, Özmert E, Erenler F. The effect of multiple injections of ranibizumab on retinal nerve fiber layer thickness in patients with age-related macular degeneration. Curr Eye Res. 2015;40(1):87–92. doi:10.3109/02713683.2014.917190
   PubMed Web of Science ®Google Scholar
• Parlak M, Oner FH, Saatci AO. The long-term effect of intravitreal ranibizumab on retinal nerve fiber layer thickness in exudative age-related macular degeneration. Int Ophthalmol. 2015;35(4):473–480. doi:10.1007/s10792-014-9972-2
   PubMed Web of Science ®Google Scholar
• Beck M, Munk MR, Ebneter A, Wolf S, Zinkernagel MS. Retinal ganglion cell layer change in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Am J Ophthalmol. 2016;167:10–17. doi:10.1016/j.ajo.2016.04.003
   PubMed Web of Science ®Google Scholar
• Jo YJ, Kim WJ, Shin IH, Kim JY. Longitudinal changes in retinal nerve fiber layer thickness after intravitreal anti-vascular endothelial growth factor therapy. Korean J Ophthalmol. 2016;30(2):114–120. doi:10.3341/kjo.2016.30.2.114
   PubMedGoogle Scholar
• Zhang Z, Yang X, Jin H, et al. Changes in retinal nerve fiber layer thickness after multiple injections of novel VEGF decoy receptor conbercept for various retinal diseases. Sci Rep. 2016;6(1):38326. doi:10.1038/srep38326
   PubMedGoogle Scholar
• Zucchiatti I, Cicinelli MV, Parodi MB, et al. Effect of intravitreal ranibizumab on ganglion cell complex and peripapillary retinal nerve fiber layer in neovascular age-related macular degeneration using spectral domain optical coherence tomography. Retina. 2017;37(7):1314–1319. doi:10.1097/IAE.0000000000001360
   PubMed Web of Science ®Google Scholar
• Gómez-Mariscal M, Puerto B, Muñoz-Negrete FJ, de Juan V, Rebolleda G. Acute and chronic optic nerve head biomechanics and intraocular pressure changes in patients receiving multiple intravitreal injections of anti-VEGF. Graefes Arch Clin Exp Ophthalmol. 2019;257(10):2221–2231. doi:10.1007/s00417-019-04354-7
   PubMed Web of Science ®Google Scholar
• Valverde-Megías A, Ruiz-Calvo A, Murciano-Cespedosa A, Hernández-Ruiz S, Martínez-de-la-Casa JM, García-Feijoo J. Long-term effect of intravitreal ranibizumab therapy on retinal nerve fiber layer in eyes with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1459–1466. doi:10.1007/s00417-019-04325-y
   PubMed Web of Science ®Google Scholar
• Blindness GBD, Vision Impairment C, Briant PS, Vision Loss Expert Group of the Global Burden of Disease S. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9(2):e144–e60. doi:10.1016/S2214-109X(20)30489-7
   PubMed Web of Science ®Google Scholar
• Griffith JF, Goldberg JL. Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center. Clin Ophthalmol. 2015;9:1275–1284. doi:10.2147/OPTH.S85851
   PubMedGoogle Scholar
• Du J, Patrie JT, Prum BE, Netland PA, Shildkrot YE. Effects of intravitreal anti-VEGF therapy on glaucoma-like progression in susceptible eyes. J Glaucoma. 2019;28(12):1035–1040. doi:10.1097/IJG.0000000000001382
   PubMed Web of Science ®Google Scholar
• Lee WJ, Kim YK, Kim YW, et al. Rate of macular ganglion cell-inner plexiform layer thinning in glaucomatous eyes with vascular endothelial growth factor inhibition. J Glaucoma. 2017;26(11):980–986. doi:10.1097/IJG.0000000000000776
   PubMed Web of Science ®Google Scholar
• Saleh R, Karpe A, Zinkernagel MS, Munk MR. Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2017;255(4):817–824. doi:10.1007/s00417-017-3590-4
   PubMed Web of Science ®Google Scholar
• Swaminathan SS, Kunkler AL, Quan AV, et al. Rates of RNFL thinning in patients with suspected or confirmed glaucoma receiving unilateral intravitreal injections for exudative AMD. Am J Ophthalmol. 2021;226:206–216. doi:10.1016/j.ajo.2020.12.016
   PubMed Web of Science ®Google Scholar
• Park CH, Lee KI, Park HY, Lee JH, Kim IT, Park CK. Changes in the retinal nerve fiber layer after intravitreal injections of bevacizumab in glaucoma patients. J Korean Ophthalmol Soc. 2014;55(5):693–701. doi:10.3341/jkos.2014.55.5.693
   Google Scholar
• Rud’ko AS, Budzinskaya MV, Andreeva IV, Karpilova MA, Smirnova TV. Effect of intravitreal injections of ranibizumab and aflibercept on the retinal nerve fiber layer in patients with concomitant neovascular age-related macular degeneration and glaucoma. Vestn Oftalmol. 2019;135(5. Vyp. 2):177–183. doi:10.17116/oftalma2019135052177
   PubMedGoogle Scholar
• Kopić A, Biuk D, Barać J, Vinković M, Benašić T, Kopić V. Retinal nerve fiber layer thickness in glaucoma patients treated with multiple intravitreal anti-VEGF (bevacizumab) injections. Acta Clin Croat. 2017;56(3):406–414. doi:10.20471/acc.2017.56.03.07
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Smeeth L, Guttmann A, et al. The reporting of studies conducted using observational routinely-collected health data (record) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.1001885
   PubMed Web of Science ®Google Scholar
• Alonso V, Santos JV, Pinto M, et al. Health records as the basis of clinical coding: is the quality adequate? A qualitative study of medical coders’ perceptions. Health Inf Manag. 2020;49(1):28–37. doi:10.1177/1833358319826351
   PubMedGoogle Scholar
• Mwanza JC, Budenz DL, Warren JL, et al. Retinal nerve fibre layer thickness floor and corresponding functional loss in glaucoma. Br J Ophthalmol. 2015;99(6):732–737. doi:10.1136/bjophthalmol-2014-305745
   PubMed Web of Science ®Google Scholar
• Corp. I. IBM SPSS Statistics for Mac. In: Armonk. 27.0 ed. Armonk, NY: IBM Corp; 2020.
   Google Scholar
• Park YR, Jee D. Changes in peripapillary retinal nerve fiber layer thickness after pattern scanning laser photocoagulation in patients with diabetic retinopathy. Korean J Ophthalmol. 2014;28(3):220–225. doi:10.3341/kjo.2014.28.3.220
   PubMedGoogle Scholar